Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Wednesday, November 11, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4396 POSTS
0 COMMENTS
Neoadjuvant Docetaxel, Oxaliplatin, and S-1, as Part of Perioperative Chemotherapy, Prolongs...
Ogkologos
-
August 19, 2024
0
New on NCI’s Websites for August 2024
Ogkologos
-
August 16, 2024
0
EMA Recommends Granting a Marketing Authorisation for Generic Nilotinib
Ogkologos
-
August 16, 2024
0
Neoadjuvant Chemotherapy with mFOLFIRINOX Followed by Chemoradiotherapy Improves Survival in Patients...
Ogkologos
-
August 14, 2024
0
Understanding the Risk of Second Cancers After CAR T-Cell Therapy
Ogkologos
-
August 13, 2024
0
Virchow: The Largest Foundation Model for Computational Pathology To Date
Ogkologos
-
August 13, 2024
0
Adding Blinatumomab to Consolidation Chemotherapy Improves OS in Adult Patients in...
Ogkologos
-
August 12, 2024
0
EMA Recommends Granting a Marketing Authorisation for Generic Enzalutamide
Ogkologos
-
August 9, 2024
0
Drug Combo JAKs Up Immunotherapy in Two Clinical Trials
Ogkologos
-
August 8, 2024
0
Efficacy and Safety of Adding Antiangiogenesis Therapy to First-Line Immunochemotherapy in...
Ogkologos
-
August 8, 2024
0
1
...
73
74
75
...
440
Page 74 of 440
MOST POPULAR
Socioeconomic Deprivation Associated with Worse Survival in Patients with Cancer Included...
March 23, 2021
Program Helps Medically Underserved, Minority Cancer Survivors Be More Active
July 3, 2024
Reflections from our chief scientist: The rise of the whole organism
February 4, 2022
EMA Recommends Extension of Indications for Talazoparib
November 27, 2023
Load more
HOT NEWS
Darolutamide Maintenance Improves Outcomes in Patients with mCRPC Who Were Previously...
Removing senescent immune cells could be the key to preventing some...
FDA Approves New Interchangeable Biosimilar to Pertuzumab
Cancer in My Community: Overcoming Inequities in Care in Argentina
Ελληνικά
English (UK)
